- Share
-
-
arroba
. . . Everyone, it seems, has a problem with peer review at top-tier journals. The recent discrediting of stem cell work by Woo-Suk Hwang at Seoul National University sparked media debates about the system’s failure to detect fraud. Authors, meanwhile, are lodging a range of complaints: Reviewers sabotage papers that compete with their own, strong papers are sent to sister journals to boost their profiles, and editors at commercial journals are too young and invariably make mistakes about which papers to reject or accept. Still, even senior scientists are reluctant to give specific examples of being shortchanged by peer review, worrying that the move could jeopardize their future publications. . . .
[See also Frank Tipler’s article on peer review in UNCOMMON DISSENT: INTELLECTUALS WHO FIND DARWINISM UNCONVINCING.]